chitosan has been researched along with trinitrobenzenesulfonic acid in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (10.53) | 18.2507 |
| 2000's | 4 (21.05) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, T; Muranishi, S; Odoriba, T; Okabe, S; Suzuki, T; Tanaka, C; Terabe, A; Tozaki, H; Yamamoto, A | 1 |
| Fujita, T; Muranishi, S; Odoriba, T; Okabe, S; Terabe, A; Tozaki, H; Yamamoto, A | 1 |
| Fujita, T; Muranishi, S; Odoriba, T; Okabe, S; Okada, N; Suzuki, T; Terabe, A; Tozaki, H; Yamamoto, A | 1 |
| Machida, Y; Onishi, H; Oosegi, T | 2 |
| Crcarevska, MS; Dodov, MG; Gjorgoski, I; Goracinova, K; Petrusevska, G | 1 |
| Inphonlek, S; Pimpha, N; Sunintaboon, P; Tabata, Y | 1 |
| Carda, C; Diez-Sales, O; Fadda, AM; Loy, G; Manconi, M; Merino, V; Merino-Sanjuan, M; Mura, C; Nácher, A; Ruiz, A | 1 |
| Abdolghaffari, AH; Abdollahi, M; Atyabi, F; Baeeri, M; Baghaei, A; Dinarvand, R; Fazeli, MR; Jamalifar, H; Mahbod, M; Mahdaviani, P; Mohammadirad, A; Saadatzadeh, A | 1 |
| Bautzová, T; Dvořáčková, K; Gajdziok, J; Lamprecht, A; Pellequer, Y; Rabišková, M; Spilková, J | 1 |
| Rana, V; Singh, K; Suri, R; Tiwary, AK | 1 |
| Cheng, YH; Gefen, A; Lin, FH; Liu, CC; Yang, SH | 1 |
| Caddeo, C; Castangia, I; Catalán-Latorre, A; Díez-Sales, O; Fadda, AM; Fernàndez-Busquets, X; Manconi, M; Merino, V; Nácher, A | 1 |
| Deygen, IM; Kudryashova, ЕV | 1 |
| Cui, YL; Gao, LN; Wang, GF; Wang, QS; Zhou, J | 1 |
| Kamboj, S; Khurana, RK; Rana, V; Sethi, S; Sharma, R; Singh, A | 1 |
| Lakshmanan, P; Newton, AMJ | 1 |
| Cao, X; Chen, S; Duan, L; Guo, Z; Han, Z; Han, ZC; Hou, H; Li, Z; Liu, N; Liu, Y; Qi, X; Wang, C; Zhang, D; Zhang, S; Zhao, Q | 1 |
| Dong, Y; Gao, T; Huo, C; Song, C; Sun, Y; Wang, P; Xing, J; Yan, Y; Zhang, R | 1 |
19 other study(ies) available for chitosan and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Colon-specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats.
Topics: Animals; Capsules; Chitin; Chitosan; Colitis, Ulcerative; Colon; Male; Pentanoic Acids; Peroxidase; Pyridines; Rats; Rats, Wistar; Thromboxane-A Synthase; Trinitrobenzenesulfonic Acid | 1999 |
Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Chitin; Chitosan; Colitis; Colon; Disease Models, Animal; Drug Carriers; Male; Mesalamine; Models, Biological; Rats; Rats, Wistar; Reproducibility of Results; Sulfasalazine; Trinitrobenzenesulfonic Acid | 1999 |
Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Capsules; Carboxymethylcellulose Sodium; Chitin; Chitosan; Colitis, Ulcerative; Colon; Drug Carriers; Intestinal Absorption; Male; Mesalamine; Peroxidase; Rats; Rats, Wistar; Tissue Distribution; Trinitrobenzenesulfonic Acid | 2002 |
Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis.
Topics: Acrylates; Administration, Oral; Animals; Anti-Inflammatory Agents; Area Under Curve; Biological Availability; Cecum; Chitosan; Colitis; Colon; Gastric Mucosa; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Male; Microscopy, Electron, Scanning; Microspheres; Particle Size; Pharmaceutical Vehicles; Polymers; Prednisolone; Rats; Rats, Wistar; Surface Properties; Tissue Distribution; Trinitrobenzenesulfonic Acid | 2008 |
Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Chitosan; Colitis; Drug Delivery Systems; Intestinal Absorption; Intestinal Mucosa; Male; Microscopy, Electron, Scanning; Microspheres; Organ Size; Particle Size; Polymethacrylic Acids; Prednisolone; Rats; Rats, Wistar; Tissue Distribution; Trinitrobenzenesulfonic Acid | 2008 |
Bioefficacy of budesonide loaded crosslinked polyelectrolyte microparticles in rat model of induced colitis.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Budesonide; Calcium Chloride; Chitosan; Colitis; Cross-Linking Reagents; Delayed-Action Preparations; Disease Models, Animal; Drug Delivery Systems; Electrolytes; Glucuronic Acid; Hexuronic Acids; Male; Microspheres; Polymethacrylic Acids; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2009 |
Gene delivery efficacy of polyethyleneimine-introduced chitosan shell/poly(methyl methacrylate) core nanoparticles for rat mesenchymal stem cells.
Topics: Amines; Animals; Buffers; Chitosan; DNA; Emulsions; Male; Mesenchymal Stem Cells; Nanoparticles; Particle Size; Polyethyleneimine; Polymethyl Methacrylate; Rats; Rats, Wistar; Surface Properties; Time Factors; Transfection; Trinitrobenzenesulfonic Acid | 2010 |
N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
Topics: Absorption; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chitosan; Colitis; Colon; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Freeze Drying; Intestinal Mucosa; Lymphocyte Activation; Male; Mesalamine; Organ Size; Peroxidase; Polymers; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2011 |
Biochemical and pathological evidences on the benefit of a new biodegradable nanoparticles of probiotic extract in murine colitis.
Topics: Animals; Chitosan; Colitis; Cytokines; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Freeze Drying; Inflammation Mediators; Lactic Acid; Lipid Peroxidation; Male; Nanoparticles; Pilot Projects; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Probiotics; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2012 |
Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Buffers; Caffeic Acids; Chemistry, Pharmaceutical; Chitosan; Colitis; Colon; Disease Models, Animal; Drug Compounding; Drug Implants; Drug Stability; Gastrointestinal Agents; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypromellose Derivatives; Male; Methylcellulose; Rats; Rats, Wistar; Rutin; Solubility; Technology, Pharmaceutical; Time Factors; Trinitrobenzenesulfonic Acid; Zinc Acetate | 2012 |
Exploiting the synergistic effect of chitosan-EDTA conjugate with MSA for the early recovery from colitis.
Topics: Adhesiveness; Animals; Calorimetry, Differential Scanning; Chitosan; Colitis; Colon; Drug Synergism; Edetic Acid; Hydrogen-Ion Concentration; Mesalamine; Microscopy, Electron, Scanning; Powders; Rats; Rats, Sprague-Dawley; Spectroscopy, Fourier Transform Infrared; Tablets; Trinitrobenzenesulfonic Acid | 2013 |
Thermosensitive hydrogel made of ferulic acid-gelatin and chitosan glycerophosphate.
Topics: Caspase 3; Cell Line; Chitosan; Coumaric Acids; Drug Carriers; Gelatin; Gene Expression Regulation; Glycerophosphates; Glycosaminoglycans; Hydrogels; Intervertebral Disc; Rheology; Temperature; Trinitrobenzenesulfonic Acid | 2013 |
Therapeutic efficacy of quercetin enzyme-responsive nanovesicles for the treatment of experimental colitis in rats.
Topics: Animals; Antioxidants; Chitosan; Coated Materials, Biocompatible; Colitis; Drug Carriers; Male; Nanoparticles; Quercetin; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2015 |
New versatile approach for analysis of PEG content in conjugates and complexes with biomacromolecules based on FTIR spectroscopy.
Topics: Adsorption; Biopolymers; Chitosan; Hydrogen-Ion Concentration; Liposomes; Polyethylene Glycols; Reproducibility of Results; Spectroscopy, Fourier Transform Infrared; Static Electricity; Thermodynamics; Trinitrobenzenesulfonic Acid | 2016 |
Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
Topics: Alginates; Animals; Biological Availability; Chitosan; Colitis, Ulcerative; Colon; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Flavonoids; Glucuronic Acid; Hexuronic Acids; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Microspheres; Rats; Rats, Sprague-Dawley; Solubility; Trinitrobenzenesulfonic Acid | 2016 |
Investigating the potential of Tamarindus indica pectin-chitosan conjugate for reducing recovery period in TNBS induced colitis.
Topics: Animals; Chitosan; Colitis; Disease Models, Animal; Drug Delivery Systems; Humans; Pectins; Plant Exudates; Rats; Tablets; Tamarindus; Trinitrobenzenesulfonic Acid; Wound Healing | 2017 |
Comparative Efficacy of Chitosan, Pectin Based Mesalamine Colon Targeted Drug Delivery Systems on TNBS-induced IBD Model Rats.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Colon; Disease Models, Animal; Drug Delivery Systems; Humans; Inflammatory Bowel Diseases; Mesalamine; Pectins; Rats; Rats, Wistar; Reactive Oxygen Species; Trinitrobenzenesulfonic Acid; Ulcer | 2020 |
IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE
Topics: Animals; Cells, Cultured; Chitosan; Colitis, Ulcerative; Colon; Dinoprostone; Disease Models, Animal; Drug Carriers; Female; Humans; Hydrogels; Insulin-Like Growth Factor I; Intestinal Mucosa; Macrophage Activation; Macrophages, Peritoneal; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Placenta; Pregnancy; Primary Cell Culture; Trinitrobenzenesulfonic Acid | 2020 |
Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Biomarkers; Chitosan; Colitis; Colon; Drug Delivery Systems; Drug Liberation; Gene Expression; Heparin, Low-Molecular-Weight; Kinetics; Male; Mice; Nanoparticles; Peroxidase; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Treatment Outcome; Trinitrobenzenesulfonic Acid | 2020 |